07:00 , Mar 16, 2015 |  BC Week In Review  |  Clinical News

Insti HIV/Syphilis Multiplex Test regulatory update

bioLytical received CE Mark approval for the Insti HIV/Syphilis Multiplex Test to simultaneously detect syphilis, HIV-1 and HIV-2 antibodies. The in vitro test detects antibodies in human whole blood, serum or plasma and delivers results...
07:00 , Aug 13, 2007 |  BC Week In Review  |  Clinical News

Insti HIV-1 Rapid Antibody Test regulatory update

bioLytical said its Insti HIV-1 Rapid Antibody Test was approved in Mexico and Venezuela as a point-of-care test for HIV-1 antibodies in human whole blood, serum or plasma. bioLytical Laboratories Inc. , Richmond, B.C.  ...
07:00 , Aug 6, 2007 |  BC Week In Review  |  Clinical News

Insti HIV-1 Rapid Antibody Test update

bioLytical began a U.S. trial in about 2,500 patients. bioLytical Laboratories Inc. , Richmond, B.C.   Product: Insti HIV-1 Rapid Antibody Test   Business: Diagnostic   Molecular target: Not applicable   Description: In vitro test...
08:00 , Nov 14, 2005 |  BC Week In Review  |  Clinical News

Insti HIV kit regulatory update

Health Canada approved the Insti HIV, a rapid test kit to detect HIV infection in a point-of-care setting. bioLytical Laboratories Inc. , Richmond, B.C.   Product: Insti HIV kit   Business: Diagnostic  ...